Table 1.

Mean change in GLOESS from baseline to weeks 12 and 24 in patients with DAS28 ≤3.2 at week 24, with or without DAS28 ≥1.2 improvement at week 12

		DAS28 ≥1.2 improvement at week 12 and DAS28 ≤3.2 at week 24	DAS28 <1.2 change at week 12 and DAS28 ≤3.2 at week 24
MCPs 2–5 joint set	Week 12	−4.2 (−5.8 to −2.5)	−4.3 (−6.2 to −2.4)
	Week 24	−5.5 (−7.0 to −4.0)	−6.9 (−10.6 to −3.2)
22 paired joint set	Week 12	−12.6 (−17.2 to −8.0)	−10.6 (−16.7 to −4.5)
	Week 24	−17.1 (−22.4 to −11.8)	−18.2 (−28.6 to −7.8)
Reduced (9 paired joints) set	Week 12	−6.1 (−8.0 to −4.1)	−4.3 (−6.2 to −2.4)
	Week 24	−7.3 (−9.6 to −5.1)	−6.7 (−11.1 to −2.3)

Data are mean change (95% CI).

DAS28, Disease Activity Score 28; GLOESS, Global OMERACT-EULAR Synovitis Score; MCP, metacarpophalangeal joint.